Antioxidant Effect of Tianwang Buxin Pills A Traditional Chinese Medicine Formula: Double-Blind, Randomized Controlled Trial

被引:12
|
作者
Gim, Gyeong Taek [2 ]
Kim, Hyung-Min [3 ]
Kim, Jiyoung [1 ]
Kim, Jongwoo [4 ]
Whang, Wei-Wan [1 ]
Cho, Seung-Hun [1 ]
机构
[1] Kyung Hee Univ, Med Ctr, Hosp Korean Med, Dept Neuropsychiat, Seoul 130701, South Korea
[2] Kyung Hee Univ, Grad Sch, Dept EW Med, Seoul 130701, South Korea
[3] Kyung Hee Univ, Coll Oriental Med, Dept Pharmacol, Seoul 130701, South Korea
[4] Hosp Korean Med, EW NeoMed Ctr, Dept Neuropsychiat, Seoul, South Korea
来源
AMERICAN JOURNAL OF CHINESE MEDICINE | 2009年 / 37卷 / 02期
关键词
Tianwang Buxin Pills; Randomized Controlled; Double Blind; d-ROMs Test; SRI; WHOQOL-BREF; Oxidative Stress; OXIDATIVE STRESS; EXERCISE;
D O I
10.1142/S0192415X09006795
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Reactive oxygen species (ROS) and their derivatives play important roles in the development of diseases such as, cardiovascular disease, ischemic disease, and aging. Much effort has been devoted to finding both an effective and non-toxic antioxidant traditional Chinese medicine (TCM) herbal formula. Tianwang Buxin Pills (TBPs) have been used in TCM to treat mild cognitive impairment and palpitations. Recently, research has revealed that TBPs are effective against oxidative stress and psychological stress in experimental studies. However, randomized controlled trials (RCT) are rare. This study was conducted to assess the antioxidative and anti-stress effects of TBPs by analyzing (determination) reactive oxygen metabolites (d-ROMs test) of the blood, the stress response inventory (SRI), and the Korean version of the WHO Quality of Life Scale Abbreviated Version (WHOQOL-BREF) in 39 healthy volunteers (Placebo group = 20, TBPs group = 19) before and after oral administration of TBPs for 4 weeks. However, d-ROMs test, SRI, and WHOQOL-BREF values did not differ significantly between the two groups. These results indicate that TBPs do not effectively restrain ROS or their derivatives.
引用
收藏
页码:227 / 239
页数:13
相关论文
共 50 条
  • [41] Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial
    Zhang, Hong Ping
    Wang, Lei
    Wang, Zhen
    Xu, Xian Rong
    Zhou, Xian Mei
    Liu, Gang
    He, Lv Yuan
    Wang, Jun
    Hsu, Alan
    Li, Wei Min
    Wang, Gang
    RESPIRATORY MEDICINE, 2018, 140 : 42 - 49
  • [42] Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial
    Miyazaki, Shougo
    Hagihara, Akihito
    Kanda, Ryo
    Mukaino, Yoshito
    Nobutomo, Koichi
    CLINICAL JOURNAL OF PAIN, 2009, 25 (05): : 438 - 444
  • [43] Safety and Tolerance of a Novel Anti-Regurgitation Formula: A Double-Blind, Randomized, Controlled Trial
    Bellaiche, Marc
    Ludwig, Thomas
    Arciszewska, Malgorzata
    Bongers, Anke
    Gomes, Cedrico
    Swiat, Agnieszka
    Dakhlia, Faouzi
    Piollet, Anne
    Oozeer, Raish
    Vandenplas, Yvan
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (05): : 579 - 585
  • [44] Effect of herbal medicine (Jodeungsan) on migraine: A double-blind randomized clinical trial
    Kim, Seyoung
    Seo, Jihye
    Kim, Cheol-hyun
    Sung, Hyun-Kyung
    Go, Ho-Yeon
    Jung, Woo Sang
    Kwon, Seungwon
    Kwak, Minjung
    Lee, Sangkwan
    INTEGRATIVE MEDICINE RESEARCH, 2022, 11 (04)
  • [45] A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency
    Cao, Xiao-jing
    Huang, Xuchun
    Liu, Jian
    Ma, Fei
    Zeng, Yuyan
    Chen, Changqian
    Wang, Ji-ju
    Nie, Guangning
    Wang, Xiao-yun
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2018, 25 (08): : 918 - 926
  • [46] Uterine blood flow change in a randomized double-blind clinical trial of a traditional Chinese herbal formula treating primary dysmenorrhea.
    Liu, J.-Y.
    Liu, Y.-S.
    Yeh, L. L. Liang
    Lin, K.-S.
    Tsai, T.-F.
    Wang, L.-H.
    FERTILITY AND STERILITY, 2007, 88 : S192 - S193
  • [47] A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine granules for the treatment of menopausal symptoms by stages
    Fu, Shu-fei
    Zhao, Ying-qiang
    Ren, Ming
    Zhang, Jun-hua
    Wang, Yue-fei
    Han, Li-feng
    Chang, Yan-xu
    Fan, Guan-wei
    Wang, Hong
    Huang, Yu-hong
    Zhai, Jing-bo
    Dong, Jin-ying
    Li, Xin
    Ai, Ju-qing
    Zhang, Han
    Zhu, Yan
    Zhang, Bo-li
    Sun, Li-kang
    Fan, Xiang
    Gao, Xiu-mei
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (03): : 311 - 323
  • [48] Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Chen, Suzhen
    Xu, Zhi
    Li, Yinghui
    Wang, Tianyu
    Yue, Yingying
    Hou, Zhenghua
    You, Linlin
    Lu, Na
    Yin, Yingying
    Liu, Xiaoyun
    Tan, Liangliang
    Ji, Houcheng
    Shi, Yaoran
    Xin, Xiaoyun
    Jiang, Wenhao
    Yuan, Yonggui
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 669 - 679
  • [49] Treatment of Constipation in Long-Term Care with Chinese Herbal Formula: A Randomized, Double-Blind Placebo-Controlled Trial
    Huang, Chien-Hsun
    Su, Yi-Chang
    Li, Tsai-Chung
    Lee, Shih-Chang
    Lin, Jui-Shan
    Chiu, Tai-Yuan
    Lue, Hung-Chi
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2011, 17 (07) : 639 - 646
  • [50] Chinese Medicine Shensongyangxin Is Effective for Patients with Bradycardia: Results of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Liu, Yunfang
    Li, Ning
    Jia, Zhenhua
    Lu, Feng
    Pu, Jielin
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014